← Open Payments lookup

MEGAN DINGUS: Open Payments

NPI 1548701279 · FRUITLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$498 in 22 payments from 11 companies in 2025. Trend: 2023 $410 · 2024 $1,180 · 2025 $498

Food & beverage: $498
CompanyPaymentsAmount
ABBVIE INC.8$139
Otsuka America Pharmaceutical, Inc.1$89
Vanda Pharmaceuticals Inc.2$44
Neurocrine BioSciences, Inc.2$43
Supernus Pharmaceuticals, Inc.2$38
Alkermes, Inc.2$37
Teva Pharmaceuticals USA, Inc.1$27
Axsome Therapeutics, Inc.1$24
E.R. Squibb & Sons, L.L.C.1$23
Takeda Pharmaceuticals U.S.A., Inc.1$20

Products named: VRAYLAR, REXULTI, HETLIOZ, INGREZZA, Qelbree, ARISTADA, UZEDY, Auvelity.

Industry payments across MD — which companies pay providers there.